FR2390408A1 - Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus - Google Patents

Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus

Info

Publication number
FR2390408A1
FR2390408A1 FR7714396A FR7714396A FR2390408A1 FR 2390408 A1 FR2390408 A1 FR 2390408A1 FR 7714396 A FR7714396 A FR 7714396A FR 7714396 A FR7714396 A FR 7714396A FR 2390408 A1 FR2390408 A1 FR 2390408A1
Authority
FR
France
Prior art keywords
labelled
radioactive isotope
hydroxy
blood
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7714396A
Other languages
English (en)
Inventor
Groupe De Recherche Pour Grami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Signify France SAS
Original Assignee
Philips France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips France SAS filed Critical Philips France SAS
Priority to FR7714396A priority Critical patent/FR2390408A1/fr
Publication of FR2390408A1 publication Critical patent/FR2390408A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21H—OBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION
    • G21H5/00—Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for 
    • G21H5/02—Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for  as tracers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne un procédé de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses dérivés halogénés ou sulfonés, ainsi que le produit chimique obtenu selon ce procédé. L'invention décrit egalement un procédé de marquage des éléments figurés du sang, et les produits pharmaceutiques ainsi obtenus. L'invention a trait aux applications médicales de ces produits radioactifs, notamment la visualisation des foyers thrombo-emboliques récents et des abcès et les déterminations de volumes hématiques sanguins. Application : produits pharmaceutiques.
FR7714396A 1977-05-11 1977-05-11 Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus Withdrawn FR2390408A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7714396A FR2390408A1 (fr) 1977-05-11 1977-05-11 Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7714396A FR2390408A1 (fr) 1977-05-11 1977-05-11 Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus

Publications (1)

Publication Number Publication Date
FR2390408A1 true FR2390408A1 (fr) 1978-12-08

Family

ID=9190656

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7714396A Withdrawn FR2390408A1 (fr) 1977-05-11 1977-05-11 Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus

Country Status (1)

Country Link
FR (1) FR2390408A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017355A2 (fr) * 1979-03-21 1980-10-15 AMERSHAM INTERNATIONAL plc Composition d'un complexe d'indium-111 avec de l'oxine
FR2474314A1 (fr) * 1979-12-31 1981-07-31 Byk Mallinckrodt Cil Bv Solution aqueuse de dosage radiologique pour animaux a sang chaud
EP0096871A2 (fr) * 1982-06-14 1983-12-28 Yale University Composition pour faire une image de cellules sanguines
WO1991014664A1 (fr) * 1990-03-23 1991-10-03 Robert Charles Hider Complexes metalliques
WO1997025074A2 (fr) * 1996-01-12 1997-07-17 Redcell Canada, Inc. Ancres de proteines seriques et cellulaires destinees a l'imagerie diagnostique

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017355A2 (fr) * 1979-03-21 1980-10-15 AMERSHAM INTERNATIONAL plc Composition d'un complexe d'indium-111 avec de l'oxine
EP0017355A3 (en) * 1979-03-21 1981-01-28 Amersham International Plc Indium-iii oxine complex composition
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
FR2474314A1 (fr) * 1979-12-31 1981-07-31 Byk Mallinckrodt Cil Bv Solution aqueuse de dosage radiologique pour animaux a sang chaud
EP0096871A2 (fr) * 1982-06-14 1983-12-28 Yale University Composition pour faire une image de cellules sanguines
EP0096871A3 (fr) * 1982-06-14 1984-03-28 Yale University Composition pour faire une image de cellules sanguines
WO1991014664A1 (fr) * 1990-03-23 1991-10-03 Robert Charles Hider Complexes metalliques
WO1997025074A2 (fr) * 1996-01-12 1997-07-17 Redcell Canada, Inc. Ancres de proteines seriques et cellulaires destinees a l'imagerie diagnostique
WO1997025074A3 (fr) * 1996-01-12 1997-11-13 Redcell Inc Ancres de proteines seriques et cellulaires destinees a l'imagerie diagnostique

Similar Documents

Publication Publication Date Title
EP0063002B1 (fr) Peptides radiomarqués dérivés de la fibrine réticulée, pour localiser des thrombus et compositions injectables les contenant
Holtzman et al. Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma
Thomas et al. Gold-Precipitation by Heparin of a Protein in Rabbit and Human Plasma
EP0111415B1 (fr) Procédé de préparation d'une trousse de produit lyophilisé pour la visualisation radiographique
US4416865A (en) Radiopharmaceuticals for localization of thromboembolic disease
Wahl et al. Thrombocytopenia associated with antiheparin antibody
Fenn et al. The exchange of radioactive potassium with body potassium
Knight et al. Radiolabeling of fibrinogen using the iodogen technique
JPS542343A (en) Radioactive diagnostic agent labelled with tecnetium 99m and production thereof
Jasin Mechanism of trapping of immune complexes in joint collagenous tissues.
Mager et al. Turnover of purine nucleotides in rabbit erythrocytes I. Studies in vivo
US4443426A (en) Blood agent
Astedt No crossreaction between circulating plasminogen activator and urokinase
FR2390408A1 (fr) Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus
Ouchi et al. Detection of intravascular thrombi by means of I131-labeled plasmin
US4057615A (en) Method of tagging excipients with 99M technetium
US3574818A (en) Diagnostic for rheumatism
England et al. Studies on the transcobalamins
US5455021A (en) Isotopic tracer composition and method for making and using same
Harwig et al. In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent
Landaw et al. Decreased surface charge and accelerated senescence of red blood cells following neuraminidase treatment
Miller et al. Influence of phenytoin on theophylline clearance
JPS6058927A (ja) 放射能標識血小板製剤
Egberg et al. On fibrin distribution in organs of dogs during defibrination with the thrombin-like enzyme from Bothrops atrox
Fiehn et al. Macrocreatine kinase in plasma: A cause for a false positive CK-MB immunoinhibition test

Legal Events

Date Code Title Description
ST Notification of lapse